Evanston, ILNCT05566769Now EnrollingIRB Ready

Neuromyelitis Optica Clinical Trial in Evanston, IL

Access cutting-edge neuromyelitis optica treatment through this clinical trial at a research site in Evanston. Study-provided care at no cost to qualified participants.

Sponsored by Ad scientiam

Quick Self-Assessment

See if you qualify for this Evanston location

Preparing your pre-screening questions…

Expert Care in Evanston

Access neuromyelitis optica specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related neuromyelitis optica treatment provided free

Apply for This Evanston Location

Check if you qualify for this neuromyelitis optica clinical trial in Evanston, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Evanston

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Evanston site if eligible
  4. 4Begin participation

About This Neuromyelitis Optica Study in Evanston

NMOSDCopilot is a digital tool developed for the self-assessment of Neuromyelitis Optica Spectrum Disorder symptoms that impact patients' functioning and quality of life. It has been co-designed with the help of patient advocacy groups, NMOSD patients and medical experts. It includes a smartphone-based application for patients, connected to a web portal developed for healthcare professionals (HCSPs). The patient application is composed of vision, walking, cognition, and dexterity e-active tests inspired by clinical standards, as well as e-questionnaires. The HCP web portal is a desktop-based software that allows HCPs to access the results generated via the patient application and facilitates remote monitoring of patients' symptoms. The objectives of this study are to validate the accuracy, reliability and reproducibility of the unsupervised at-home self-assessment of symptoms on the patient's smartphone versus the standard in-clinic testing, as well as to evaluate the safety of use of the tool, its usability, and satisfaction towards the patient application among NMOSD patients, and the HCP web dashboard among HCPs.

Sponsor: Ad scientiam

Who Can Participate

Inclusion Criteria

Aged over 18 years old
NMOSD as defined by the 2015 international consensus diagnostic criteria (AQP4+ only)
With NMOSD treatment (treatment must be unchanged since 6 months before enrollment, and 1 month for analgesics, antidepressants, neuroleptics)
With no evidence of relapse in the past 3 months before enrollment
Who have read the information sheet and signed the informed consent form
Able to use a smartphone
Owns a personal smartphone which version is above 13 for IOS and 8 for Android included
Able to read language in which the mobile application is available and able to understand pictograms

Exclusion Criteria

Evidence of neurologic, rheumatologic or psychiatric disorder other than NMOSD, including but not limited to major head trauma, seizures or systemic medical diseases that are likely to affect cognitive, upper limb or lower limb functioning
Pregnant and nursing women
Person under guardianship or curatorship
Bedridden patients or patients with a daily activity of less than 2 hours per day
Current drugs or/and alcohol abuse that could influence performance on the tests (clinician's judgment)
Subject has participated in another clinical study within the previous 30 days of screening or is currently participating in another study that, in the opinion of the Investigator, might interfere with the participant's full participation in the study or confound the assessment of the participant or outcome of the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Evanston?

Yes, this clinical trial (NCT05566769) has an active research site in Evanston, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Neuromyelitis Optica Treatment Options in Evanston, IL

If you're searching for neuromyelitis optica treatment options in Evanston, IL, this clinical trial (NCT05566769) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Evanston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuromyelitis optica specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all neuromyelitis optica clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in Evanston, IL

See all interstitial cystitis clinical trials recruiting in Evanston — not just this study.

Browse Interstitial Cystitis Trials in Evanston

Ready to Join in Evanston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Evanston, IL